These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

857 related articles for article (PubMed ID: 22722403)

  • 41. BET bromodomain inhibitors show anti-papillomavirus activity in vitro and block CRPV wart growth in vivo.
    Morse MA; Balogh KK; Brendle SA; Campbell CA; Chen MX; Furze RC; Harada IL; Holyer ID; Kumar U; Lee K; Prinjha RK; Rüdiger M; Seal JT; Taylor S; Witherington J; Christensen ND
    Antiviral Res; 2018 Jun; 154():158-165. PubMed ID: 29653131
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interfering with bromodomain epigenome readers as therapeutic option in mucoepidermoid carcinoma.
    Markman RL; Webber LP; Nascimento Filho CHV; Reis LA; Vargas PA; Lopes MA; Zanella V; Martins MD; Squarize CH; Castilho RM
    Cell Oncol (Dordr); 2019 Apr; 42(2):143-155. PubMed ID: 30539410
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Epigenetic regulation and transcriptional memory in development; selection facilitating prudence.
    Verma A; Maini J; Jain S; Ghasemi M; Kohli S; Brahmachari V
    Int J Dev Biol; 2020; 64(1-2-3):181-201. PubMed ID: 32659007
    [TBL] [Abstract][Full Text] [Related]  

  • 44.
    Nord JA; Wynia-Smith SL; Gehant AL; Jones Lipinski RA; Naatz A; Rioja I; Prinjha RK; Corbett JA; Smith BC
    Front Endocrinol (Lausanne); 2022; 13():923925. PubMed ID: 36176467
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Bromodomains: Structure, function and pharmacology of inhibition.
    Ferri E; Petosa C; McKenna CE
    Biochem Pharmacol; 2016 Apr; 106():1-18. PubMed ID: 26707800
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The BET Protein Inhibitor Apabetalone Rescues Diabetes-Induced Impairment of Angiogenic Response by Epigenetic Regulation of Thrombospondin-1.
    Mohammed SA; Albiero M; Ambrosini S; Gorica E; Karsai G; Caravaggi CM; Masi S; Camici GG; Wenzl FA; Calderone V; Madeddu P; Sciarretta S; Matter CM; Spinetti G; Lüscher TF; Ruschitzka F; Costantino S; Fadini GP; Paneni F
    Antioxid Redox Signal; 2022 Apr; 36(10-12):667-684. PubMed ID: 34913726
    [No Abstract]   [Full Text] [Related]  

  • 47. Bromodomain analysis of Brd2-dependent transcriptional activation of cyclin A.
    Sinha A; Faller DV; Denis GV
    Biochem J; 2005 Apr; 387(Pt 1):257-69. PubMed ID: 15548137
    [TBL] [Abstract][Full Text] [Related]  

  • 48. BET Proteins as Targets for Anticancer Treatment.
    Stathis A; Bertoni F
    Cancer Discov; 2018 Jan; 8(1):24-36. PubMed ID: 29263030
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The conserved 12-amino acid stretch in the inter-bromodomain region of BET family proteins functions as a nuclear localization signal.
    Fukazawa H; Masumi A
    Biol Pharm Bull; 2012; 35(11):2064-8. PubMed ID: 22971749
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Functional coupling between writers, erasers and readers of histone and DNA methylation.
    Torres IO; Fujimori DG
    Curr Opin Struct Biol; 2015 Dec; 35():68-75. PubMed ID: 26496625
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Bromodomain inhibitors: what does the future hold?
    Bhattacharya S; Piya S; Borthakur G
    Clin Adv Hematol Oncol; 2018 Jul; 16(7):504-515. PubMed ID: 30067623
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The chromatin-specific transcription elongation factor FACT comprises human SPT16 and SSRP1 proteins.
    Orphanides G; Wu WH; Lane WS; Hampsey M; Reinberg D
    Nature; 1999 Jul; 400(6741):284-8. PubMed ID: 10421373
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Covalent-Fragment Screening of BRD4 Identifies a Ligandable Site Orthogonal to the Acetyl-Lysine Binding Sites.
    Olp MD; Sprague DJ; Goetz CJ; Kathman SG; Wynia-Smith SL; Shishodia S; Summers SB; Xu Z; Statsyuk AV; Smith BC
    ACS Chem Biol; 2020 Apr; 15(4):1036-1049. PubMed ID: 32149490
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Targeting Cancer Cells with BET Bromodomain Inhibitors.
    Xu Y; Vakoc CR
    Cold Spring Harb Perspect Med; 2017 Jul; 7(7):. PubMed ID: 28213432
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Epigenetic Priming and Development of New Combination Therapy Approaches.
    Meneceur S; Grunewald CM; Niegisch G; Hoffmann MJ
    Methods Mol Biol; 2023; 2684():259-281. PubMed ID: 37410240
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Selective degradation of BET proteins with dBET1, a proteolysis-targeting chimera, potently reduces pro-inflammatory responses in lipopolysaccharide-activated microglia.
    DeMars KM; Yang C; Castro-Rivera CI; Candelario-Jalil E
    Biochem Biophys Res Commun; 2018 Feb; 497(1):410-415. PubMed ID: 29448097
    [TBL] [Abstract][Full Text] [Related]  

  • 57. BRD3 and BRD4 BET Bromodomain Proteins Differentially Regulate Skeletal Myogenesis.
    Roberts TC; Etxaniz U; Dall'Agnese A; Wu SY; Chiang CM; Brennan PE; Wood MJA; Puri PL
    Sci Rep; 2017 Jul; 7(1):6153. PubMed ID: 28733670
    [TBL] [Abstract][Full Text] [Related]  

  • 58. JQ1 affects BRD2-dependent and independent transcription regulation without disrupting H4-hyperacetylated chromatin states.
    Handoko L; Kaczkowski B; Hon CC; Lizio M; Wakamori M; Matsuda T; Ito T; Jeyamohan P; Sato Y; Sakamoto K; Yokoyama S; Kimura H; Minoda A; Umehara T
    Epigenetics; 2018; 13(4):410-431. PubMed ID: 30080437
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Brd4 is essential for IL-1β-induced inflammation in human airway epithelial cells.
    Khan YM; Kirkham P; Barnes PJ; Adcock IM
    PLoS One; 2014; 9(4):e95051. PubMed ID: 24759736
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Targeting chromatin defects in selected solid tumors based on oncogene addiction, synthetic lethality and epigenetic antagonism.
    Morel D; Almouzni G; Soria JC; Postel-Vinay S
    Ann Oncol; 2017 Feb; 28(2):254-269. PubMed ID: 28426098
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 43.